```

[House Report 107-182]
[From the U.S. Government Publishing Office]

107th Congress                                                   Report
                        HOUSE OF REPRESENTATIVES
 1st Session                                                    107-182

======================================================================

 
    URGING INCREASED FEDERAL FUNDING FOR JUVENILE (TYPE 1) DIABETES 
                                RESEARCH

                                _______
                                

   August 1, 2001.--Referred to the House Calendar and ordered to be 
                                printed

                                _______
                                

 Mr. Tauzin, from the Committee on Energy and Commerce, submitted the 
                               following

                              R E P O R T

                     [To accompany H. Con. Res. 36]

      [Including cost estimate of the Congressional Budget Office]

    The Committee on Energy and Commerce, to whom was referred 
the concurrent resolution (H. Con. Res. 36) urging increased 
Federal funding for juvenile (Type 1) diabetes research, having 
considered the same, report favorably thereon with amendments 
and recommend that the concurrent resolution as amended be 
agreed to.

                                CONTENTS

                                                                   Page
Amendment........................................................     1
Purpose and Summary..............................................     2
Background and Need for Legislation..............................     2
Hearings.........................................................     2
Committee Consideration..........................................     2
Committee Votes..................................................     3
Committee Oversight Findings.....................................     3
Statement of General Performance Goals and Objectives............     3
New Budget Authority, Entitlement Authority, and Tax Expenditures     3
Committee Cost Estimate..........................................     3
Congressional Budget Office Estimate.............................     3
Federal Mandates Statement.......................................     4
Advisory Committee Statement.....................................     4
Constitutional Authority Statement...............................     4
Applicability to Legislative Branch..............................     4
Section-by-Section Analysis of the Legislation...................     4
Changes in Existing Law Made by the Bill, as Reported............     5

                               AMENDMENT

    The amendments strike all after the resolving clause and 
strike the preamble and insert a new resolving clause and 
preamble which appear in italic type in the reported concurrent 
resolution. The amendments also amend the title of the 
concurrent resolution.
    The following shows the preamble and the subsequent 
provisions of the reported concurrent resolution:

Whereas over one million Americans suffer from juvenile (type 1) diabetes, 
a chronic, genetically determined, debilitating disease affecting every 
organ system:

Whereas 13,000 children a year--35 each day--are diagnosed with juvenile 
diabetes;

Whereas 17,000 adults a year--46 each day--are diagnosed with juvenile 
diabetes;

Whereas juvenile diabetes is one of the most costly chronic diseases of 
childhood;

Whereas insulin treats but does not cure this potentially deadly disease 
and does not prevent the complications of diabetes, which include 
blindness, heart attack, kidney failure, stroke, nerve damage, and 
amputations; and

Whereas the Diabetes Research Working Group, a nonpartisan advisory board 
established to advise Congress, has called for an accelerated and expanded 
diabetes research program at the National Institutes of Health and has 
recommended an increase in Federal funding for diabetes research at the 
National Institutes of Health over each of the next five years: Now, 
therefore, be it

    Resolved by the House of Representatives (the Senate concurring), 
That Federal funding for diabetes research should be increased annually 
as recommended by the Diabetes Research Working Group so that a cure 
for juvenile diabetes can be found.

    The following shows the amendment to the title:
    Amend the title so as to read: ``A concurrent resolution 
urging increased Federal funding for juvenile (type 1) diabetes 
research.''.

                          PURPOSE AND SUMMARY

    H. Con. Res. 36 declares that Federal funding for diabetes 
research should be increased so that a cure for juvenile 
diabetes can be found.

                  BACKGROUND AND NEED FOR LEGISLATION

    More than one million Americans have type 1 (juvenile) 
diabetes. Type 1 diabetes is a disease which strikes children 
suddenly, makes them insulin dependent for life, and carries 
the constant threat of life threatening complications. Someone 
is diagnosed with type 1 diabetes every hour, and this 
devastating disease also afflicts adult populations. Type 1 
diabetes impairs the body's ability to manufacture and use 
insulin, a hormone necessary to metabolize sugar or glucose. 
Most people with diabetes must take either insulin injections 
or oral medications to lower blood sugar levels. When blood 
sugar levels are not maintained properly, people with diabetes 
are often threatened with blood sugar emergencies (either 
hyperglycemia or hypoglycemia), which can be life threatening.
    Even with insulin, type 1 diabetes usually results in a 
drastic reduction in quality of life and shortens the average 
life span by 15 years. Each year, approximately 30,000 
Americans are diagnosed with type 1 diabetes, over 13,000 of 
whom are children.

                                HEARINGS

    The Subcommittee on Health held a hearing entitled, 
``Advancing the Health of the American People: Addressing 
Various Public Health Needs'' on June 27, 2001. The 
Subcommittee heard testimony on H. Con. Res. 36 at the hearing. 
The witness testifying on the bill was Mr. Larry Balthazar.

                        COMMITTEE CONSIDERATION

    On Wednesday, July 11, 2001, the Subcommittee on Health met 
in an open markup session and approved H. Con. Res. 36 for Full 
Committee consideration, as amended, by voice vote, a quorum 
being present. On Wednesday, July 18, 2001, the Full Committee 
met in open markup session and ordered H. Con. Res. 36 
favorably reported to the House, as amended, by unanimous 
consent, a quorum being present.

                            COMMITTEE VOTES

    Clause 3(b) of rule XIII of the Rules of the House of 
Representatives requires the Committee to list the record votes 
on the motion to report legislation and amendments thereto. 
There were no record votes taken in connection with ordering H. 
Con. Res. 36 reported. A motion by Mr. Tauzin to order H. Con. 
Res. 36 reported to the House, as amended, was agreed to by 
unanimous consent.

                      COMMITTEE OVERSIGHT FINDINGS

    Pursuant to clause 3(c)(1) of rule XIII of the Rules of the 
House of Representatives, the Committee held an oversight 
hearing and made findings that are reflected in this report.

         STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES

    The goal of H. Con. Res. 36 is to urge increased Federal 
funding for juvenile (type 1) diabetes research.

   NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX EXPENDITURES

    In compliance with clause 3(c)(2) of Rule XIII of the Rules 
of the House of Representatives, the Committee finds that H. 
Con. Res. 36, a concurrent resolution urging increased Federal 
funding for juvenile (type 1) diabetes research, would result 
in no new or increased budget authority, entitlement authority, 
or tax expenditures or revenues.

                        COMMITTEE COST ESTIMATE

    The Committee adopts as its own the cost estimate prepared 
by the Director of the Congressional Budget Office pursuant to 
section 402 of the Congressional Budget Act of 1974.

                  CONGRESSIONAL BUDGET OFFICE ESTIMATE

    Pursuant to clause 3(c)(3) of Rule XIII of the Rules of the 
House of Representatives, the following is the cost estimate 
provided by the Congressional Budget Office pursuant to section 
402 of the Congressional Budget Act of 1974:

                                     U.S. Congress,
                               Congressional Budget Office,
                                     Washington, DC, July 30, 2001.
Hon. W.J. ``Billy'' Tauzin,
Chairman, Committee on Energy and Commerce,
House of Representatives, Washington, DC.
    Dear Mr. Chairman: The Congressional Budget Office has 
prepared the enclosed cost estimates for the following 
Concurrent Resolutions approved by the Committee on Energy and 
Commerce:
          H. Con. Res. 25, expressing the sense of the Congress 
        regarding tuberous sclerosis;
          H. Con. Res. 36, urging increased federal funding for 
        juvenile (Type I) diabetes research;
          H. Con. Res. 61, expressing support for a National 
        Reflex Sympathetic Dystrophy (RSD) Awareness Month.
    If you wish further details on these estimates, we will be 
pleased to provide them. The CBO staff contact is Charles 
Betley.
            Sincerely,
                                          Barry B. Anderson
                                    (For Dan L. Crippen, Director).
    Enclosure.

H. Con. Res. 36--Urging increased federal funding for juvenile (Type I) 
        diabetes research

    H. Con. Res. 36 would express the resolve of the Congress 
to increase annually federal funding of research to find a cure 
for juvenile diabetes, according to the recommendations of the 
Diabetes Research Working Group. CBO estimates that passing H. 
Con. Res. 36 would result in no significant cost to the federal 
government. The resolution would not affect direct spending or 
receipts; therefore, pay-as-you-go procedures would not apply.
    The CBO staff contact is Charles Betley. This estimate was 
approved by Peter H. Fontaine, Deputy Assistant Director for 
Budget Analysis.

                       federal mandates statement

    The Committee adopts as its own the estimate of Federal 
mandates prepared by the Director of the Congressional Budget 
Office pursuant to section 423 of the Unfunded Mandates Reform 
Act.

                      advisory committee statement

    No advisory committees within the meaning of section 5(b) 
of the Federal Advisory Committee Act were created by this 
legislation.

                   constitutional authority statement

    Pursuant to clause 3(d)(1) of rule XIII of the Rules of the 
House of Representatives, the Committee finds that the 
Constitutional authority for this legislation is provided in 
Article I, section 8, clause 3, which grants Congress the power 
to regulate commerce with foreign nations, among the several 
States, and with the Indian tribes.

                  applicability to legislative branch

    The Committee finds that the legislation does not relate to 
the terms and conditions of employment or access to public 
services or accommodations within the meaning of section 
102(b)(3) of the Congressional Accountability Act.

             section-by-section analysis of the legislation

    This legislation expresses the sense of Congress that 
Federal funding for diabetes research be increased in 
accordance with the recommendations of the Diabetes Research 
Working Group so that a cure for juvenile diabetes can be 
found.

         changes in existing law made by the bill, as reported

    This legislation does not amend any existing Federal 
statute.

                                

```